Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SHE:000766)

Market Cap	20.50B +32.2%
Revenue (ttm)	1.25B -10.8%
Net Income	57.48M +9.9%
EPS	0.06 +2.3%
Shares Out	966.49M
PE Ratio	356.65
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	19,626,028
Average Volume	14,693,384
Open	21.16
Previous Close	20.99
Day's Range	20.72 - 21.36
52-Week Range	15.66 - 30.20
Beta	0.30
RSI	31.58
Earnings Date	Apr 22, 2026

About SHE:000766

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of pharmaceutical products in China. Its products covers anti-tumor, microbial, cardiovascular, heat-clearing and detoxification, digestive system, skeletal muscle system, gynecological system, nervous system, and other fields. The company also provides bone peptides, protective chemical medicines, cardiovascular and cerebrovascular chinese patent medicines, heat-clearing and detoxifying medicines, an...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 1,532
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000766

Financial Performance

In 2024, SHE:000766's revenue was 1.32 billion, a decrease of -10.23% compared to the previous year's 1.47 billion. Earnings were 56.44 million, an increase of 28.46%.